-+ 0.00%
-+ 0.00%
-+ 0.00%

Livzon Pharmaceutical Group Gets NMPA Approval to Begin Clinical Trials of NS-041 Tablet for Depression

Reuters·12/21/2025 10:15:28

Please log in to view news